Literature DB >> 9155607

Heart failure and atrial fibrillation: current concepts and controversies.

M P Van den Berg1, A E Tuinenburg, H J Crijns, I C Van Gelder, A T Gosselink, K I Lie.   

Abstract

Heart failure and atrial fibrillation are very common, particularly in the elderly. Owing to common risk factors both disorders are often present in the same patient. In addition, there is increasing evidence of a complex, reciprocal relation between heart failure and atrial fibrillation. Thus heart failure may cause atrial fibrillation, with electromechanical feedback and neurohumoral activation playing an important mediating role. In addition, atrial fibrillation may promote heart failure; in particular, when there is an uncontrolled ventricular rate, tachycardiomyopathy may develop and thereby heart failure. Eventually, a vicious circle between heart failure and atrial fibrillation may form, in which neurohumoral activation and subtle derangement of rate control are involved. Treatment should aim at unloading of the heart, adequate control of ventricular rate, and correction of neurohumoral activation. Angiotensin converting enzyme inhibitors may help to achieve these goals. Treatment should also include an attempt to restore sinus rhythm through electrical cardioversion, though appropriate timing of cardioversion is difficult. His bundle ablation may be used to achieve adequate rate control in drug refractory cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155607      PMCID: PMC484722          DOI: 10.1136/hrt.77.4.309

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state.

Authors:  M P van den Berg; H J Crijns; A T Gosselink; S A van den Broek; H J Hillege; D J van Veldhuisen; K I Lie
Journal:  Br Heart J       Date:  1993-08

2.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

Authors:  M Edner; K Caidahl; L Bergfeldt; B Darpö; N Edvardsson; M Rosenqvist
Journal:  Br Heart J       Date:  1995-09

3.  Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.

Authors:  M P Van Den Berg; H J Crijns; D J Van Veldhuisen; N Griep; P J De Kam; K I Lie
Journal:  J Card Fail       Date:  1995-12       Impact factor: 5.712

4.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

5.  Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease.

Authors:  A T Gosselink; H J Crijns; H P Hamer; H Hillege; K I Lie
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094

6.  Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure.

Authors:  I F Goldenberg; W R Lewis; V C Dias; J T Heywood; W R Pedersen
Journal:  Am J Cardiol       Date:  1994-11-01       Impact factor: 2.778

7.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

Review 8.  Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses.

Authors:  Y M Pinto; H Buikema; W H van Gilst
Journal:  Clin Exp Hypertens       Date:  1995-04       Impact factor: 1.749

9.  Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up.

Authors:  A T Gosselink; E B Bijlsma; M L Landsman; H J Crijns; K I Lie
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272

View more
  11 in total

Review 1.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

Review 2.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

3.  Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.

Authors:  A E Tuinenburg; I C Van Gelder; M P Van Den Berg; J Brügemann; P J De Kam; H J Crijns
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

4.  Persistent Atrial Fibrillation And Atrial Flutter Complicated By Tachycardiomyopathy Because Of Intermittent Conduction Through Accessory Pathway.

Authors:  L Valeri; A Coppolino; G Rossetti; A Vado; G Amoroso; G Bricco; A Battisti; L Correndo; S Dogliani; A Magliarditi; D Pancaldo; M De Benedictis; A Bassignana; B Doronzo
Journal:  J Atr Fibrillation       Date:  2016-04-30

5.  Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.

Authors:  Christiana Schernthaner; Maximilian Pichler; Bernhard Strohmer
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

Review 6.  Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors:  Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Authors:  Nileshkumar J Patel; Aashay Patel; Kanishk Agnihotri; Dhaval Pau; Samir Patel; Badal Thakkar; Nikhil Nalluri; Deepak Asti; Ritesh Kanotra; Sabeeda Kadavath; Shilpkumar Arora; Nilay Patel; Achint Patel; Azfar Sheikh; Neil Patel; Apurva O Badheka; Abhishek Deshmukh; Hakan Paydak; Juan Viles-Gonzalez
Journal:  World J Cardiol       Date:  2015-07-26

8.  A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Michel White; O James Ekundayo; Thomas E Love; Inmaculada Aban; Bo Liu; Wilbert S Aronow; Ali Ahmed
Journal:  Eur Heart J       Date:  2009-06-16       Impact factor: 29.983

Review 9.  Prevention of and medical therapy for atrial arrhythmias in heart failure.

Authors:  A U Khand; J G F Cleland; P C Deedwania
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

10.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.